Wellington Management Group
INSY

Wellington Management Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Wellington Management Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-65,603
Closed -$604K – 2352
2016
Q4 		$604K Sell
65,603
-44,474
-40% -$502K ﹤0.01% 1967
2016
Q3 		$1.3M Sell
110,077
-15,328
-12% -$233K ﹤0.01% 1776
2016
Q2 		$1.62M Sell
125,405
-278
-0.2% -$4.05K ﹤0.01% 1655
2016
Q1 		$2.01M Hold
125,683
– – ﹤0.01% 1604
2015
Q4 		$3.6M Buy
125,683
+35,609
+40% +$987K ﹤0.01% 1462
2015
Q3 		$2.56M Hold
90,074
– – ﹤0.01% 1555
2015
Q2 		$3.23M Buy
90,074
+44,396
+97% +$1.38M ﹤0.01% 1534
2015
Q1 		$1.33M Buy
45,678
+6,878
+18% +$182K ﹤0.01% 1788
2014
Q4 		$818K Sell
38,800
-26,600
-41% -$526K ﹤0.01% 1900
2014
Q3 		$1.27M Buy
+65,400
New +$1.03M ﹤0.01% 1775
2013
Q4 		– Sell
-81,600
Closed -$952K – 2268
2013
Q3 		$952K Buy
+81,600
New +$670K ﹤0.01% 1809

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wellington Management Group's INSY Position: Q1 2017 in Review

Wellington Management Group sold out of Insys Therapeutics, Inc. (INSY) in Q1 2017, closing a stake of 65,603 shares — an estimated $604K sold.

Wellington Management Group first reported a position in INSY in Q3 2013 and held it in 11 quarters. The position peaked at $3.6M in Q4 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q1 2017.

  • Wellington Management Group reported no remaining Insys Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Wellington Management Group sold 65,603 Insys Therapeutics, Inc. shares in Q1 2017, an estimated $604K.
  • Wellington Management Group first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 11 quarters.
  • Wellington Management Group's Insys Therapeutics, Inc. position peaked at $3.6M in Q4 2015.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2017.

Based on Wellington Management Group's 13F filing for Q1 2017, filed 11 May 2017.